Caring Brands, Inc. (NASDAQ:CABR) Short Interest Down 71.0% in May

Caring Brands, Inc. (NASDAQ:CABR – Get Free Report) saw a significant drop in short interest in May. As of May 15th, there was short interest totaling 5,492 shares, a drop of 71.0% from the April 30th total of 18,964 shares. Based on an average daily trading volume, of 100,261 shares, the short-interest ratio is presently 0.1 days. Approximately 0.1% of the shares of the stock are short sold.

Caring Brands Trading Up 7.4%

Shares of Caring Brands stock opened at $1.16 on Friday. Caring Brands has a 12-month low of $0.71 and a 12-month high of $5.35. The company has a debt-to-equity ratio of 0.03, a quick ratio of 5.62 and a current ratio of 5.66. The stock has a market capitalization of $10.54 million and a PE ratio of -1.81. The firm has a 50-day moving average of $1.07.

Get Caring Brands alerts:

Caring Brands (NASDAQ:CABR – Get Free Report) last issued its earnings results on Tuesday, May 12th. The company reported ($0.27) earnings per share (EPS) for the quarter.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Caring Brands stock. Jane Street Group LLC acquired a new position in shares of Caring Brands, Inc. (NASDAQ:CABR – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 34,446 shares of the company’s stock, valued at approximately $30,000. Jane Street Group LLC owned approximately 0.25% of Caring Brands at the end of the most recent reporting period.

Caring Brands Company Profile

(Get Free Report)

We are a wellness consumer products company. We offer several over-the-counter, or (OTC) and cosmetic, consumer products. Our method of operation is to ensure that (1) the mechanism of action of all products is established, (2) efficacy is determined through controlled clinical trials, (3) products are protected by issued and filed patents, and (4) products have acceptable commercial stability. Prior to its Q3 2022 commercial launch in India as a treatment for vitiligo and psoriasis, Photocil was briefly launched in the United States markets from December 2022 until February 2023, however, was subsequently removed from the market due to insufficient sales resulting from the lack of a dedicated sales and marketing team.

Read More

• Five stocks we like better than Caring Brands
• Wall Street Is Starting to Talk About Tesla’s Endgame
• Meta’s Manus Mess: Why China Blocked the Deal and What It Means
• China Deal Ignites Boeing’s Financial Afterburners
• 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?

Receive News & Ratings for Caring Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caring Brands and related companies with MarketBeat.com's FREE daily email newsletter.